Crossject is revolutionizing needle free injection

Paragraphes
Colonne 1

Crossject is revolutionizing the administration of well-established, clinically-proven treatments and bringing unprecedented advantages to patients with its innovative, needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in less than a tenth of a second. Crossject currently has eight ZENEO® solutions in advanced stages of development, seven of which are for emergency situations.  

Zeneo illustration

 

Our news

Image de l'actualité

Patrick Alexandre: « Lorsque l’on regarde ce qui a été accompli, nous avons de réelles raisons d’être fiers. »

Résumé de l'actualité

Patrick Alexandre, PDG de Crossject, a répondu aux questions de Didier TESTOT pour LA BOURSE ET LA VIE TV.

 

Image de l'actualité

Crossject will attend BIO-Europe

Résumé de l'actualité

Crossject will attend BIO-Europe, the Europe's largest life sciences partnering conference.